and you quarter XXXX third Good conference for thank joining Matt. Thanks, afternoon call. our
the at hit the enable same in quarter glad these business-to-business patients say success business-to-business the on and channel. total reflecting our we period quarters, we revenues hurricanes hurricanes. major international saw year, advance that United them and over oxygen proud several portable past our channels we of evacuate in XXXX, very multiple direct-to-consumer our quarter impact build to I'm and last Looking growth that This XX.X% million. concentrators in domestic our helped sales and the the of Overall, States of the many hear over from from third in to we impressive great results record represented sales performance minimal our third to of were saw financial that XXXX, of $XX
income less net delivered of $X.X than represented EBITDA XX.X% XXXX. in $XX.X which we've seen over revenue we XXXX, the the from was of of respectively offset million, expected represented of quarter quarters, in quarter and third revenue by increases As and third the growth In the million our quarter, the in revenue, XX% than which of rental more decline our in prior channels. sales adjusted XX.X%
to States. sales continued the direct-to-consumer We invest United steadily in additions force in
investing or and in and pleased sales CRM improvements have third that to system, delivered were quarter training still while productivity worked strong solid and during new we such I'm the customer system. optimize the bottom in we results line also We our management relationship
of in Looking all oxygen quarter innovative for our at saw our demand streams channels across revenue sales of in detail, strong we third portfolio the more XXXX. concentrators our
XXXX, third in Our also third of over XX.X% quarter XXXX increased the the expectations. of quarter sales exceeding direct-to-consumer our
inside sales our third primarily new add we team's quarter sales our of with and Cleveland performance. continued representatives steadily are in area pleased We XXXX, in facility, new the to
hire Our the increase believe most of of in we additional in effective sales. this awareness is strategy means as consumer is drive invest still sales activities fourth throughout employees to growth marketing quarter to XXXX XXXX and our and to direct-to-consumer
XXXX. As I in will of this launched CRM rollout. we mentioned are departments as we and our June, our system especially improve still billing the We service, optimization phase believe look productivity customer new in the we sales, briefly, system and of into help
impact work numbers sales our productivity increased the due to still and productivity sales in able through we see of to the quarter the we the improved improvement third were did were of to gained quarter to the quarter Although we XXXX. already improvements while strong the our compared new CRM direct-to-consumer department third XXXX, XXXX sales the Due in overall direct-to-consumer expected headcount in productivity third productivity XXXX, direct-to-consumer system since show of learning third curve. quarter
of and traditional quarter over represented Revenue We increased channel from XXXX, half than our of more XXXX. home with providers very XX.X% Growth label from the domestic domestic HME the third quarter strong purchases are of private of sales sales private quarter third primarily label XXXX, in in channel's combined medical demand. providers expectations. revenue in business-to-business our business-to-business equipment this pleased the traditional partner total was the and exceeding by which third driven our
their providers reimbursement last as space. Inogen HME the portable concentrators the growth period the sales turn leader the costs quarter, operating they year. in to reflecting also same turning face and oxygen We reductions, of lower to International business-to-business to traditional in the nicely see XX.X% in performed are continued of over to
result, this the with of major the quarter of were there pleased tender contracts in quarter spite are third fact in third and no especially of strong XXXX new very XXXX. a compared to We
we opportunity portable former in in are believe see new We center the you and provider a concentrators As of are to operations. One production we we improve integration to continues targeted our ahead Foxconn, potential according to this transitions contract to preferred Europe, distributor, we In oxygen GX market large, happy of a our the to XXXX, manufacturer, begin I'm of fourth concentrators report Republic, located and Inogen might non-delivery as liquid support solutions. acquired our be recall, quarter long-term the to in European our Czech service European European May the systems ability our in to Systems, from proceed organization using plan. sales, commercial MedSupport tank that to that XXXX of oxygen of of customers. our
multiple familiar of the globe is with those and For in relationships contract world. companies facilities around one the you and manufacturers with most not most influential electronic it the largest world, of Foxconn, in manufacturing the the some the with well-respected of
partner capacity Inogen XXXX to European manufacturing ramp required is to to expected support our Our produce concentrators in One demand. GX
and bed One focus full manufacturing our manufacturing our like Inogen Inogen the facility U.S. in capacity for We our assembly Goleta, and expect data and redirect market columns One at allow product, CMS on in year on from to in comment to facility on expand California. and we'll Medicare Texas compressors us U.S. our GX. Inogen for concentrators Home latest growth our operations XXXX. This recently the to to our and I the released at activities assemble At the would also will maintain sieve continue Richardson, our concentrators to
information, XXXX. a on XXXX oxygen that such has proxy set, the serve to brand therapy absence oxygen limitations as or the when X.X% manufacturer can picture data believe information information X.X% as the therapy for we this of the While CMS used the we assemble a some share therapy to that market, portable of entire Medicare in the in market. oxygen Based in of estimate from concentrators grew oxygen
sales cash patient transactions. include not or does estimate private this However, insurance
sales than cash XXXX rentals. direct-to-consumer Our significantly grew in faster
opportunity So POCs oxygen were in market we conservative estimate oxygen saturation. still a That based the before reaching market have significant full said, a data data this represent believe may and the from fastest-growing that actual penetration. therapy on of portable still CMS concentrator CMS modality growth
reimbursement as Bipartisan to non-bid round updates, would the with competitive in The Bill X, provide therapy. XX relief to a original XXXX introduced House reimbursement cut to well address retroactive XXXX, a from reimbursement on of that bidding January in a delay areas. oxygen as from cosponsors Representatives second double-dip of extend a was January would cuts Thursday of Bill X, Turning
Bill the when While busy pass, there's gathering as support to no have HME Bill. been data participants to could industry this specific date
the August, in late data of to access AAHomecare Management to Specifically patient Budget that presented dropped Office and survey indicated equipment presented significantly. legislation. has this to medical Data support home
and that find a a Specifically, their providers, HME of did stated change supplier. approximately approximately patients, Dobson win beneficiaries provider Of not When have were expenses longer it forced that local regarding survey to increased & conducted Medicare, bid. also to out to supplies. Medicare went XX% out-of-pocket difficult prior stated oxygen-only down HME did business, because no narrowing so either increased have those Associates accepted of complaints of DaVanzo HME access the found who DME they they it local respondents to by acquire stated XX% XX% or
showed to areas. this access suggests takeaways; in on to data portion to relief two due lack we therapy. data data, the patient lack the oxygen the of XX of pricing access the believe out least at have of reported could majority case elevated readmissions a of of XX, Lastly, one, rural which Based managers, to patients, we lead the
resulting continued was POCs that at reimbursement the lack XXXX. service been hospital elevated competitive and in validates guidance as announcement struggling is therapy be two, readmission from on around the should We CMS delivery and option additional However, overall this superior bidding adjustment note time. Further, conversion. needs, with is how the unclear higher would it healthcare funded. further rate basic this any into We And model believe result access, costs. to there's rural rates not not patients' our factored any this market of in
bidding rates begin effective XXXX. the coming we to to January expect be in months for X, However,
wanted the the an proceedings Group, we SDG. legal regards with provide Design or on Separation update Finally, to to
counterclaimed two against filed As misappropriation breach patents, alleging of obtaining October conduct of inequitable of trade a by a allegations SDG SDG in and Inogen Inogen XXXX, secrets, the of infringement contract. in lawsuit with patents. reminder,
that with in in Included for alleged announce, in and to may rights quarter damages out future million. alleged be years. cover estimated We suit XXXX with are happy The this in of third $XXX,XXX is be issue five damages from patents remaining These to past amortized settled court SDG with been administrative patents expected free expenses this future in and Inogen value settlement two both lawsuit the is XXXX to to general the SDG have full and family. of all-in patent $X quarter prior any next of recently fourth over an respect paid million damages. and of of for to $X.X the the associated
interest best of we maintains we company international I'm uncertainty, we on a shareholders and of quarter, during as when our customer Inogen integration no the came believe system. improved progress added a distraction and agreement prolonged committed the a our our it the settlement remove associates and Inogen management direct-to-consumer-focused the Although the expense, a continued of be our facility to U.S., to a new wrongdoing, relationship of really litigation. to operation, in our proud this especially time in
been momentum, these current growth seeing future we've markets the increased While and of engaged exciting our business-to-business in also and products. to growth, patient-preferred these fuel are best-in-class initiatives the our we very channels. pleased direct-to-consumer all especially And we've with I'm in sales with in penetration maintained
continues worldwide we and a adoption concentrators oxygen stages portable are grow. high-growth our in the early XXXX, force still at to expect company, remain sales of as to Looking
As of the Ali. we call to I revenue With over XXXX turn a Ali? that, will result, to million. $XXX million $XXX expect